StockData
Ecovyst Inc. logo

Ecovyst Inc. (ECVT) stock analysis

ECVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3050% above fair value
$10.82+0.17 (+1.60%)

Close on Nov 11, 2026Market cap $1.18BP/E 33.8Yield –

StockData Score

Prices as of Nov 11, 2026How the score works

Value1Growth2Performance3Health3Dividend0

Mixed9 of 30 checks passed

Ecovyst passes 9 of the 30 checks behind our score; 8 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
1/6
Growth
2/6
Past performance
3/6
Financial health
3/6
Dividend
0/6

What stands out

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 24.0% of total debt.

  • Guidance raised

    Ecovyst raised its 2026 Sales outlook on Aug 5, 2026.

  • P/B below the industry

    Ecovyst's price-to-book of 1.95 is below the Chemicals and Allied Products median of 2.86.

  • Growing faster than the industry

    Revenue grew 44.6% over the last twelve months; the Chemicals and Allied Products median is 0.1%.

What to watch

  • Margin of safety under 20%

    The price is 49.9% above fair value, so there is no margin of safety.

  • Trading above fair value

    The share price of $10.82 is above our fair value estimate of $7.22.

  • Return on equity under 15%

    Return on equity was 5.9% over the last twelve months and averaged -1.1% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 5.4%, below the 10% that usually covers the cost of capital.

Valuation1/6
  • P/E above its 5-year median

    Ecovyst's P/E of 33.8 is above its own 5-year median of 17.1.

  • P/E above the industry

    Ecovyst's P/E of 33.8 is above the Chemicals and Allied Products median of 25.2.

  • EV/EBITDA above its 5-year median

    Ecovyst's EV/EBITDA of 19.4 is above its 5-year median of 11.5.

  • P/B below the industry

    Ecovyst's price-to-book of 1.95 is below the Chemicals and Allied Products median of 2.86.

  • Trading above fair value

    The share price of $10.82 is above our fair value estimate of $7.22.

  • Margin of safety under 20%

    The price is 49.9% above fair value, so there is no margin of safety.

Growth2/6
  • Revenue growing under 10% a year

    Revenue grew -4.1% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing faster than the industry

    Revenue grew 44.6% over the last twelve months; the Chemicals and Allied Products median is 0.1%.

  • Guidance raised

    Ecovyst raised its 2026 Sales outlook on Aug 5, 2026.

  • Gross margin slipping

    Gross margin was 19.7% over the last twelve months, against 22.9% a year earlier.

Past performance3/6
  • Return on equity under 15%

    Return on equity was 5.9% over the last twelve months and averaged -1.1% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was 5.4%, below the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Ecovyst's return on equity of 5.9% is above the Chemicals and Allied Products median of -3.8%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin above its 5-year average

    Net margin was 3.7% over the last twelve months, against a 5-year average of -2.5%.

  • Net margin above the industry

    Ecovyst's net margin of 3.7% is above the Chemicals and Allied Products median of -2.8%.

Financial health3/6
  • High debt

    Debt is 81.3% of shareholders' equity, above the 40% we consider low.

  • Debt falling against equity

    Debt to equity fell from 110% five years ago to 81.3%.

  • Debt covered by cash flow

    Operating cash flow over the last twelve months equals 24.0% of total debt.

  • Interest not well covered

    Operating income covers interest expense 3.8 times; we look for at least 5.

  • Short-term assets cover short-term debts

    Current assets are 1.82 times current liabilities.

  • Elevated bankruptcy risk

    The Altman Z-score is 1.63; above 3 is the safe zone and below 1.8 the distress zone.

Dividend0/6
  • No dividend

    Ecovyst has not paid a dividend in the last twelve months.

  • Yield against Treasuries

    No dividend.

  • Yield against the market

    No dividend.

  • Dividend stability

    No dividend.

  • Earnings cover

    No dividend.

  • Cash-flow cover

    No dividend.

Scores of similar companies

Our estimate per share

$7.22

The share price is 50% above this estimate.

20%+ below
Near fair value
20%+ above
$10.82Price$7.22Fair value
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E21.1×17.1×25.2×$6.7740%
EV/EBITDA12.8×11.5×14.0×$5.8135%
P/B2.3×1.7×2.9×$12.6610%
Earnings power9.1% cost of equity––$8.1015%
Fair value$7.22100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 17.1
  • Chemicals and Allied Products median 25.2

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Medium risk

Average value traded per day
$14.38M
Value traded per 1% price move
$9.73M

Downside

Medium risk

Typical loss in a bad month
18.5%
Volatility (annualized)
31%
Sharpe ratio, 1 year
0.70
Beta to the S&P 500 (5Y)
0.85

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2014 to 2025

Gross margin

21.8%−8.6 pts over 5 years

Operating margin

9.0%−1.4 pts over 5 years

Net margin

-9.8%+46.4 pts over 5 years

See a number that looks wrong?